Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

被引:0
|
作者
Dekeyser, Catherine [1 ]
De Kesel, Pieter [2 ]
Cambron, Melissa [3 ,4 ]
Vanopdenbosch, Ludo [3 ]
Van Hijfte, Liesbeth [1 ]
Vercammen, Martine [5 ,6 ]
Laureys, Guy [1 ]
机构
[1] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium
[2] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium
[3] Dept Neurol, AZ Sint Jan Brugge, Brugge, Belgium
[4] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium
[5] Algemeen Ziekenhuis AZ Sint Jan Brugge, Dept Lab Med, Brugge, Belgium
[6] Vrije Univ Brussel, Basic Biomed Sci, Brussels, Belgium
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
multiple sclerosis; kappa free light chains; kappa FLC index; kappa IgG index; CSF kappa FLC/IgG ratio; Freelite (R)-Optilite versus N Latex (R)-BNII; BIOLOGICAL VARIATION; PERFORMANCE; BIOMARKER;
D O I
10.3389/fimmu.2024.1385231
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Cerebrospinal fluid (CSF) kappa free light chain (kappa FLC) measures gained increasing interest as diagnostic markers in multiple sclerosis (MS). However, the lack of studies comparing assay-dependent diagnostic cutoff values hinders their use in clinical practice. Additionally, the optimal kappa FLC parameter for identifying MS remains a subject of ongoing debate. Objectives: The aim of this study was to compare same-sample diagnostic accuracies of the kappa FLC index, kappa IgG index, CSF kappa FLC/IgG ratio, and isolated CSF kappa FLC (iCSF-kappa FLC) between two reference centers using different methods. Methods: Paired serum and CSF samples were analyzed for kappa FLC and albumin concentrations by Freelite (R)-Optilite (Sint-Jan Bruges hospital) and N Latex (R)-BNII (Ghent University hospital). Diagnostic performance to differentiate MS from controls was assessed using ROC curve analysis. Results: A total of 263 participants were included (MS, n = 80). Optimal diagnostic cutoff values for the kappa FLC index (Freelite (R)-Optilite: 7.7; N Latex (R)-BNII: 4.71), kappa IgG index (Freelite (R)-Optilite: 14.15, N Latex (R)-BNII: 12.19), and CSF kappa FLC/IgG ratio (Freelite (R)-Optilite: 2.27; N Latex (R)-BNII: 1.44) differed between the two methods. Sensitivities related to optimal cutoff values were 89.9% (Freelite (R)-Optilite) versus 94.6% (N Latex (R)-BNII) for the kappa FLC index, 91% (Freelite (R)-Optilite) versus 92.2% (N Latex (R)-BNII) for the kappa IgG index, and 81.3% (Freelite (R)-Optilite) versus 91.4% (N Latex (R)-BNII) for the CSF kappa FLC/IgG ratio. However, for iCSF-kappa FLC, optimal diagnostic cutoff values (0.36 mg/L) and related specificities (81.8%) were identical with a related diagnostic sensitivity of 89.9% for Freelite (R)-Optilite and 90.5% for N Latex (R)-BNII. The diagnostic performance of the kappa FLC index [area under the curve (AUC) Freelite (R)-Optilite: 0.924; N Latex (R)-BNII: 0.962] and kappa IgG index (AUC Freelite (R)-Optilite: 0.929; N Latex (R)-BNII: 0.961) was superior compared to CSF oligoclonal bands (AUC: 0.898, sensitivity: 83.8%, specificity: 95.9%). Conclusions: The kappa FLC index and the kappa IgG index seem to be excellent markers for identifying MS, irrespective of the method used for kappa FLC quantification. Based on the AUC, they appear to be the measures of choice. For all measures, optimal cutoff values differed between methods except for iCSF-kappa FLC. iCSF-kappa FLC might therefore serve as a method-independent, more cost-efficient, initial screening measure for MS. These findings are particularly relevant for clinical practice given the potential future implementation of intrathecal kappa FLC synthesis in MS diagnostic criteria and for future multicentre studies pooling data on kappa FLC measures.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] MULTIPLE-SCLEROSIS - FREE LIGHT-CHAINS IN CEREBROSPINAL-FLUID
    RUDICK, RA
    PETER, DR
    BIDLACK, JM
    KNUTSON, DW
    NEUROLOGY, 1985, 35 (10) : 1443 - 1449
  • [22] Elevated kappa free light chain in cerebrospinal fluid in Korean patients with multiple sclerosis
    Hyun, J. -W.
    Kim, W.
    Huh, S. -Y.
    Kim, G.
    Kim, Y.
    Jeong, I. H.
    Kim, S. -H.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 579 - 579
  • [23] Cerebrospinal fluid (CSF) free light chains: diagnostic and predictive relevance in multiple sclerosis and clinically isolated syndrome
    Senel, M.
    Brettschneider, J.
    Tumani, H.
    JOURNAL OF NEUROLOGY, 2013, 260 : S179 - S180
  • [24] The kappa free light chains index is an accurate diagnostic biomarker for paediatric multiple sclerosis
    Sarthou, Aurelie
    Chretien, Pascale
    Giorgi, Laetitia
    Chiron, Andrada
    Leroy, Carole
    Horellou, Philippe
    Krzysiek, Roman
    Deiva, Kumaran
    Hacein-Bey-Abina, Salima
    MULTIPLE SCLEROSIS JOURNAL, 2024,
  • [25] Kappa free light chains: Diagnostic performance in multiple sclerosis and utility in a clinical laboratory
    Martins, Dulce Alves
    Lopes, Joana
    da Silva, Ana Martins
    Morais, Catia Iracema
    Vasconcelos, Julia
    Lima, Ivete
    Carneiro, Carolina
    Neves, Esmeralda
    CLINICA CHIMICA ACTA, 2022, 528 : 56 - 64
  • [26] FREE KAPPA-LIGHT CHAINS IN MULTIPLE-SCLEROSIS SPINAL-FLUID
    RUDICK, RA
    PALLANT, A
    BIDLACK, JM
    HERNDON, RM
    ANNALS OF NEUROLOGY, 1986, 20 (01) : 63 - 69
  • [27] Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis
    Presslauer, S.
    Milosavljevic, D.
    Huebl, W.
    Bruecke, T.
    Bayer, P.
    MULTIPLE SCLEROSIS, 2006, 12 : S224 - S225
  • [28] Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis
    Presslauer, Stefan
    Milosavljevic, Dejan
    Bruecke, Thomas
    Bayer, Peter
    Huebl, Walter
    JOURNAL OF NEUROLOGY, 2008, 255 (10) : 1508 - 1514
  • [29] Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis
    S. Presslauer
    D. Milosavljevic
    T. Brücke
    P. Bayer
    W. Hübl
    Journal of Neurology, 2008, 255
  • [30] The suitability of kappa free light chains in cerebrospinal fluid diagnostics.
    Fischer, C
    Arneth, B
    Koehler, J
    Lackner, K
    CLINICAL CHEMISTRY, 2004, 50 (06) : A49 - A49